Valion Bio, Inc. (VBIO)

CIK 1787740 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Valion Bio, Inc..

Recent SEC filings

FiledFormAccession number
Sep 4, 2026SCHEDULE 13G/A0001753926-26-001726
Sep 3, 2026SCHEDULE 13D/A0001753926-26-001719
Sep 2, 2026SCHEDULE 13D/A0001753926-26-001702
Sep 1, 20268-K0001683168-26-006848
Aug 27, 2026SCHEDULE 13D/A0001753926-26-001647
Aug 27, 20268-K0001683168-26-006742
Aug 24, 2026SCHEDULE 13D/A0001753926-26-001610
Aug 24, 2026RW0001683168-26-006676
Aug 20, 20268-K/A0001683168-26-006632
Aug 19, 2026SCHEDULE 13D/A0001753926-26-001562
Aug 17, 20268-K0001683168-26-006501
Aug 14, 2026SCHEDULE 13D/A0001753926-26-001528
Aug 14, 202610-Q0001437749-26-028069
Aug 12, 2026EFFECT9999999995-26-002641
Aug 11, 2026SCHEDULE 13D/A0001753926-26-001421
Aug 6, 20268-K0001683168-26-006049
Aug 3, 2026SCHEDULE 13D0001753926-26-001299
Jul 17, 2026S-10001683168-26-005613
Jul 17, 2026SCHEDULE 13G0001838556-26-000012
Jul 17, 2026DEF 14A0001683168-26-005615
Jul 14, 20268-K0001683168-26-005497
Jul 7, 2026PRE 14A0001683168-26-005335
Jun 18, 202640001683168-26-004970
Jun 18, 20268-K0001683168-26-004956
Jun 5, 2026S-80001683168-26-004589